(Q56158294)

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Microbial influences in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

The role of microbes in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

The fundamental basis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Genetics and pathogenesis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Distinct and overlapping genetic loci in Crohn's disease and ulcerative colitis: correlations with pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

A core gut microbiome in obese and lean twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Enterotypes of the human gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Linking long-term dietary patterns with gut microbial enterotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Mucosal flora in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Does Mycobacterium avium subspecies paratuberculosis cause Crohn's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Inflammation and apoptosis in Clostridium difficile enteritis is mediated by PGE2 up-regulation of Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Bacteroides fragilis enterotoxin gene sequences in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Enterotoxigenic bacteroides fragilis: a potential instigator of colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Confirmation of association of IRGM and NCF4 with ileal Crohn's disease in a population-based cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Reduced Paneth cell alpha-defensins in ileal Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Enteric defensins are essential regulators of intestinal microbial ecology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Reduced mucosal antimicrobial activity in Crohn's disease of the colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

The gut microbiota shapes intestinal immune responses during health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Coordination of tolerogenic immune responses by the commensal microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Adaptive immunity in the host-microbiota dialog

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Microbiology of bacterial translocation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Risk factors for opportunistic infections in patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with specia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Incidence of Clostridium difficile infection in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Delay of the first onset of pouchitis by oral intake of the probiotic strain Lactobacillus rhamnosus GG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Treatment of murine colitis by Lactococcus lactis secreting interleukin-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Effectiveness of antibiotic combination therapy in patients with active ulcerative colitis: a randomized, controlled pilot trial with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Double blind, placebo controlled trial of metronidazole in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Translocation of Crohn's disease Escherichia coli across M-cells: contrasting effects of soluble plant fibres and emulsifiers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Sargramostim for active Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Steroid-sparing properties of sargramostim in patients with corticosteroid-dependent Crohn's disease: a randomised, double-blind, placebo-controlled, phase 2 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Granulocyte-macrophage colony-stimulating factor autoantibodies in murine ileitis and progressive ileal Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Granulocyte macrophage-colony-stimulating factor autoantibodies and increased intestinal permeability in Crohn disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Durable alteration of the colonic microbiota by the administration of donor fecal flora

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4

Epithelial NEMO links innate immunity to chronic intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJGSUP.2012.4